QT Medical, a Los Angeles, CA-based medtech company focused on cardiac care technology, raised USD12M in Series B funding.
The round was led by CDIB Capital and Taiwania Capital, with participation from Cathay Capital, BE Capital, TMU Biomed, and existing investor Quanta Computer.
The company intends to use the funds to accelerate market penetration, global expansion, product pipeline development, and long-term strategic planning.
Led by Ruey-Kang Chang, MD and CEO, QT Medical provides cardiac devices and services for patients with heart disease. Its flagship product, the Personal Cardiac Assistant (PCA 500)™, is a hospital-grade, resting 12-lead ECG device cleared by the FDA and CE marked for both professional and patient use. This device is wireless, digital, cloud managed, weighs 2.3 ounces, and is less than 3 inches square in size.
FinSMEs
26/09/2023